Kelly MacDonald

Ms. MacDonald joined Dynavax in 2021 as Chief Financial Officer. Ms. MacDonald joined Dynavax from Ironwood Pharmaceuticals where she held roles of increasing responsibility within the finance organization. In her final role at Ironwood, Ms. MacDonald served as Chief Accounting Officer and Vice President, Finance where she led the Company’s corporate accounting and finance processes, enterprise risk management, treasury and capital allocation strategy. While at Ironwood, she also had various other finance and accounting managerial roles where she provided financial advice on the company’s strategic planning, accounting policies, R&D portfolio management, global business development, product launches and commercial execution. Prior to joining Ironwood, Kelly was a Manager in the Health Industries Assurance Practice at PricewaterhouseCoopers, primarily serving clients in life sciences and technology sectors. Ms. MacDonald is a Certified Public Accountant, holds a B.S. in accounting from Fairfield University and a M.B.A. from the Isenberg School of Management at the University of Massachusetts.